About Docetaxel Injection Concentrate
Docetaxel Injection Concentrate is prescribed for the patients who are suffering from locally advanced as well as metastatic breast cancer. This advance medicate is recommended by the doctor after the failure of primal chemotherapy. It can be injected with the combination doxorubicin and cyclophosphamide. Offered is also indicated for the adjuvant treatment and brings relief to the patients, who are suffering from node-positive breast cancer. Docetaxel Injection Concentrate can be also prescribed with other drugs so that relief in cancer of prostate, stomach, breast, lung etc. can come to an end.
Specification
| Medicine Type | Allopathic |
| Usage | Hospital,Clinical |
| Dose | 3 ml |
| Packaging Size | 120 ml |
| Packaging Type | Box |
Advanced Chemotherapy SolutionDocetaxel Injection Concentrate delivers potent antineoplastic activity against several forms of cancer. It is designed for hospital and oncology clinic use and must be prepared and administered by qualified healthcare professionals. The product is supplied in sterile, single-use glass vials to maintain safety and efficacy throughout its shelf life.
Strict Manufacturing and Quality ControlManufactured under stringent Good Manufacturing Practice (GMP) standards, each vial of Docetaxel Injection Concentrate ensures the highest degree of purity and safety for patients. Its stable formulation maintains integrity under recommended storage, providing reliable clinical outcomes.
FAQs of Docetaxel Injection Concentrate:
Q: How is Docetaxel Injection Concentrate administered to patients?
A: Docetaxel Injection Concentrate must be administered as an intravenous infusion by qualified healthcare professionals in a controlled medical setting. It should never be given by other routes or self-administered.
Q: What types of cancer is Docetaxel Injection Concentrate used to treat?
A: Docetaxel Injection Concentrate is indicated for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric adenocarcinoma, and head and neck cancer.
Q: When should Docetaxel Injection Concentrate not be used?
A: This medication must not be used in patients with hypersensitivity to docetaxel or its excipients or in those with severe hepatic impairment. It should only be handled and administered by healthcare professionals.
Q: Where should Docetaxel Injection Concentrate be stored for maximum stability?
A: For optimal stability, store Docetaxel Injection Concentrate below 25C, protect the vials from light, and do not freeze. This maintains its efficacy for up to 24 months.
Q: What precautions should be followed during the preparation and handling of Docetaxel Injection Concentrate?
A: Being a cytotoxic agent, Docetaxel Injection Concentrate requires careful handling by trained personnel using protective equipment to avoid accidental exposure or contamination.
Q: What benefits does Docetaxel Injection Concentrate offer in cancer treatment?
A: As a potent chemotherapeutic agent, Docetaxel Injection Concentrate effectively slows or stops the growth of cancer cells, improving outcomes across several major cancer types.
Q: How should Docetaxel Injection Concentrate be used for patient safety?
A: The concentrate should be prepared and infused following strict aseptic techniques by healthcare professionals, and it should be used as a single-use dose per vial. Close patient monitoring is essential post-administration.